SignatureFD’s Altimmune ALT Stock Holding History

SignatureFD’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-490	Closed	-$1.77K	–	3470
2025 Q4	$1.77K	Buy	+490	New	+$2.14K	﹤0.01%	3002
2025 Q3	–	Sell	-318	Closed	-$1.23K	–	3381
2025 Q2	$1.23K	Buy	318 +181	+132%	+$979	﹤0.01%	2975
2025 Q1	$685	Buy	+137	New	+$868	﹤0.01%	3122

Other funds holding ALT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

SignatureFD's ALT Position: Q1 2026 in Review

SignatureFD sold out of Altimmune (ALT) in Q1 2026, closing a stake of 490 shares — an estimated $1.77K sold.

SignatureFD first reported a position in ALT in Q1 2025 and held it in 3 quarters. The position peaked at $1.77K in Q4 2025. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

SignatureFD reported no remaining Altimmune position as of Q1 2026 after selling out during the quarter.
SignatureFD sold 490 Altimmune shares in Q1 2026, an estimated $1.77K.
SignatureFD first reported a position in Altimmune in Q1 2025 and held it in 3 quarters.
SignatureFD's Altimmune position peaked at $1.77K in Q4 2025.
173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.